search
Back to results

The Impact of Higher Positive End Expiratory Pressure on Patient-Ventilator Asynchrony

Primary Purpose

Critical Illness

Status
Unknown status
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
Higher PEEP setting
Lower PEEP setting
Sponsored by
Osaka University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Illness focused on measuring patient ventilator asynchrony, positive end expiratory pressure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients ≧ 18 years old
  2. Patients with moderate to severe ARDS under mechanical ventilation* * Definition of moderate to severe ARDS is as per the Berlin definition (PaO2/FiO2 ≦ 200 mmHg with PEEP ≧ 5 cmH2O)

Exclusion Criteria:

  1. Lack of informed consent
  2. Continuous neuromuscular blockade at enrollment
  3. DNR (do-not-resuscitate)
  4. Moribund patient not expected to survive 24 hours
  5. Massive hemoptysis
  6. Increased intracranial pressure (> 18 mmHg)
  7. Existence or high risk of pneumothorax
  8. Known pregnancy
  9. Actual body weight exceeding 1 kg/cm
  10. Patient judged to be inappropriate for the trial by intensivist

Sites / Locations

  • Osaka University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

A group from higher PEEP to lower PEEP

A group from lower PEEP to higher PEEP

Arm Description

Patient allocated for this arm are received from higher to lower PEEP setting.

Patient allocated for this arm are received from lower to higher PEEP setting.

Outcomes

Primary Outcome Measures

Asynchrony index of all types of patient ventilator asynchrony at higher and lower PEEP.

Secondary Outcome Measures

Asynchrony index of each types of patient ventilator asynchrony at higher and lower PEEP.
The intensity of spontaneous breathing effort measured by esophageal manometry at higher and lower PEEP
Minute volume at higher and lower PEEP
The efficiency of diaphragmatic contraction measured by electrical activity of diaphragm at higher and lower PEEP.

Full Information

First Posted
November 1, 2020
Last Updated
July 11, 2021
Sponsor
Osaka University
search

1. Study Identification

Unique Protocol Identification Number
NCT04951960
Brief Title
The Impact of Higher Positive End Expiratory Pressure on Patient-Ventilator Asynchrony
Official Title
The Impact of Higher Positive End Expiratory Pressure on Patient-Ventilator Asynchrony in Patients With Acute Respiratory Distress Syndrome: a Cross-Over Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2020 (Actual)
Primary Completion Date
March 31, 2022 (Anticipated)
Study Completion Date
March 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Osaka University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patient-ventilator asynchrony is known to frequently occur during lung protective ventilation in patients with ARDS. Previous clinical studies showed that patient-ventilator asynchrony was associated with worse outcome in ICU. Therefore, strategies to reduce patient-ventilator asynchrony need to be established promptly. Several asynchronies, e.g., breath stacking are caused by vigorous spontaneous breathing effort. Recently, the investigators' group found that higher positive end expiratory pressure (PEEP) reduced the intensity of spontaneous breathing effort of in severe ARDS model (rabbits, pigs) and patients with ARDS. Thus, the investigators conjectured that higher PEEP may reduce the intensity of spontaneous breathing effort and thereby reduce patient-ventilator asynchrony during protective ventilation strategy, compared with lower PEEP in patients with ARDS.
Detailed Description
The cross-over study will enroll 10 participants fulfilled with the criteria of Berlin definition of moderate-to-severe ARDS and under mechanical ventilation in intensive care unit (ICU) at Osaka University Hospital. Informed consent will be obtained by legal representatives. After obtaining informed consent, participants will be randomly assigned to one of two groups: "higher PEEP - lower PEEP" or "lower PEEP - higher PEEP". PEEP, either higher or lower, will be set according to higher or lower PEEP/FIO2 table. The depth of sedation will be monitored quantitively and maintained to be the same throughout the protocol. The intensity of spontaneous breathing activity will be assessed with esophageal balloon manometry and electrical activity of diaphragm. At each PEEP setting, asynchrony index will be calculated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
Keywords
patient ventilator asynchrony, positive end expiratory pressure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
Participants, their legal representatives, and outcomes assessor are blinded.
Allocation
Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A group from higher PEEP to lower PEEP
Arm Type
Other
Arm Description
Patient allocated for this arm are received from higher to lower PEEP setting.
Arm Title
A group from lower PEEP to higher PEEP
Arm Type
Other
Arm Description
Patient allocated for this arm are received from lower to higher PEEP setting.
Intervention Type
Other
Intervention Name(s)
Higher PEEP setting
Intervention Description
PEEP levels are determined according to the higher PEEP-FiO2 tables set plateau pressure less than 30 cmH2O. The duration of measurement at each PEEP levels is 1 hour.
Intervention Type
Other
Intervention Name(s)
Lower PEEP setting
Intervention Description
PEEP levels are determined according to the lower PEEP-FiO2 tables set plateau pressure less than 30 cmH2O. The duration of measurement at each PEEP levels is 1 hour.
Primary Outcome Measure Information:
Title
Asynchrony index of all types of patient ventilator asynchrony at higher and lower PEEP.
Time Frame
Through study completion (up to 24 hours)
Secondary Outcome Measure Information:
Title
Asynchrony index of each types of patient ventilator asynchrony at higher and lower PEEP.
Time Frame
Through study completion (up to 24 hours)
Title
The intensity of spontaneous breathing effort measured by esophageal manometry at higher and lower PEEP
Time Frame
Through study completion (up to 24 hours)
Title
Minute volume at higher and lower PEEP
Time Frame
Through study completion (up to 24 hours)
Title
The efficiency of diaphragmatic contraction measured by electrical activity of diaphragm at higher and lower PEEP.
Time Frame
Through study completion (up to 24 hours)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients ≧ 18 years old Patients with moderate to severe ARDS under mechanical ventilation* * Definition of moderate to severe ARDS is as per the Berlin definition (PaO2/FiO2 ≦ 200 mmHg with PEEP ≧ 5 cmH2O) Exclusion Criteria: Lack of informed consent Continuous neuromuscular blockade at enrollment DNR (do-not-resuscitate) Moribund patient not expected to survive 24 hours Massive hemoptysis Increased intracranial pressure (> 18 mmHg) Existence or high risk of pneumothorax Known pregnancy Actual body weight exceeding 1 kg/cm Patient judged to be inappropriate for the trial by intensivist
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Takeshi Yoshida, M.D., Ph.D.
Phone
+81668795820
Email
takeshiyoshida@hp-icu.med.osaka-u.ac.jp
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Takeshi Yoshida, M.D., Ph.D.
Organizational Affiliation
Osaka University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Osaka University Hospital
City
Suita
State/Province
Osaka
Country
Japan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Takeshi Yoshida, M.D., Ph.D.
Phone
+81668795820
Email
takeshiyoshida@hp-icu.med.osaka-u.ac.jp

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Impact of Higher Positive End Expiratory Pressure on Patient-Ventilator Asynchrony

We'll reach out to this number within 24 hrs